 |
|
|
|
lymph node metastases of a thyroid gland carcinoma |
|
nonspecific synovialitis of a TEP on the right |
|
gastrointestinal stromal tumour non-responder to tyrosine kinase inhibitor therapy |
|
metastasis malignant melanoma |
|
metastasis malignant melanoma |
|
| PET/CT |
|
The PET/CT scanner from Philips is a hybrid system consisting
of the newest generation Positron Emission Tomograph with ca. 18.000 GSO single
crystal detectors made of germanium orthosilicate and a rapid multi-detector
spiral CT with a minimal slice thickness of 0,5mm.
As the scanner has an open design and an internal radius of 70 cm as well as being
able to carry a maximum weight of 195 kg, it is suitable for heavier individuals
and anyone suffering from claustrophobia.
The MDCT is like a normal CT applicable to all medical questions. |
|
The 'work horse' of the PET/CT is the examination with 18F-FDG (fluordesoxyglucose),
a radioactively labelled modified glucose which enters cells with increased glucose
metabolism (metabolic trapping). This substance is licensed as a medical drug.
In special cases, and on the basis of an individualised clinical trials (according to § 4 AMG -
German medical drug legislation), we can perform examinations with other tracers, such as
| 18F-Cholin (for bladder and prostate cancers) |
| 18F-FET (fluorethyltyrosin, for brain tumors) |
| reinem 18F-Fluor
(to illustrate bone metabolism, comparable to a common bone scintigraphy |
|
| Common indications for PET/CT-examinations are: |
| solitary pulmonary nodule (SPN) |
characterisation |
|
|
| Non-Small Cell Lung Cancer (NSCLC) |
primary staging, diagnosis, staging, re-staging, according to guidelines |
|
|
| Oesophageal cancer |
diagnosis, staging and re-staging, therapy response (35% reduction of the standardised uptake value - SUV) |
|
|
| Colorectal Cancer |
tumour localisation with rising CEA values. Diagnosis, staging and re-staging |
|
|
| Pancreas |
DD tumour / inflammation, particularly with lesions < 2cm |
|
|
| Lymphoma |
diagnosis, staging and re-staging, 15% more sensitive than CT on its own;
part of guideline for the aggressive lymphoma following the 2nd cycle
|
|
|
| Malignant Melanoma (skin cancer) |
diagnosis, staging esp. as of stadium III and re-staging (standard) |
|
|
| Breast Cancer |
in addition to conventional imaging techniques for patients with systemic metastases or re-staging for patients with elevated tumour markers or known locoregional relapses or metastases, additional to conventional imaging for analysing therapeutic response for women with locally advanced or metastasised Mamma-Ca, in case a change of the therapy regime is under discussion. Axillary lymph nodes: PET negative Patients can undergo sentinel lymphnode excision instead of complete axillary revision (no lymph edema).
NO primary diagnosis
|
|
|
| Ovarial carcinoma |
recurrent disease diagnosis, restaging |
|
|
| Prostate carcinoma |
: biochemical relapse after definitive treatment, diagnosis, undetermined PSA-increase, 18F-Cholin |
|
|
| Brain Tumours |
differentiation residual/recurrent tumour vs. radiation necrosis |
|
|
| CUP-Syndrome |
identification of the primary tumour |
|
|
| Head- and Neck tumours |
(excepting CNS and thyroid gland) diagnosis, lymph node staging and re-staging |
|
|
| Thyroid Carcinoma |
recurrent disease or residual tumour , in patients with follicular
subtype - initial therapy: Thyroidectomy and ablative radio-iodine therapy with I-131 - displaying
an elevated thyreoglobulin level of > 10 ng/dl and a negative I-131 whole body scan. |
|
|
|
|
|
|
Dr. med.
Jonas Müller-Hübenthal |
|
| Specialist in Diagnostic Radiology |
| and Nuclear Medicine |
|
For appointments please call:
+49 221 88 84 80 - 67
Mo - Fr 10 a.m. - 5 p.m (GMT) |
|
Opening Hours:
Mo - Fr 8 a.m. - 6 p.m. (GMT-1)
and by appointment |
|
route map to our Practice |
 DEUTSCH |
 ENGLISH |
|
|
